2012 Clinical Laboratory Strategies Issues




December 6

Diagnosing Central Adrenal Insufficiency

November 20

Improving Lab Reports

November 8

Assessing the Impact of a Heparin-induced Thrombocytopenia Protocol

October 25

Improving High-Sensitivity Cardiac Troponin Utilization

October 11

Repeating IGRA Tests in Healthcare Workers

September 27

Identifying Clinically Significant UTIs

September 13

Evaluating cTn in Post-operative Patients

August 23

Refining the Role of Cystatin C in Estimating GFR

August 9

Evaluating a New eGFR Equation

July 12

Assessing CYP2C19*2 Carrier Status via POCT

June 28

Improving Diagnosis of Invasive Candidiasis

June 14

Using Total Testosterone Levels to Predict Free Testosterone

May 24

Evaluating Preanalytical Effects on Immunoassays

May 10

Rethinking β-Cell Function After Type 1 Diabetes Onset

April 26

​Understanding the Lab's Role in Test Utilization

April 12

Assessing the Role of HbA1c in Gestational Diabetes

March 22

Improving the Diagnosis of Acute Kidney Injury

March 8

Taking a New Look at the hCG Discriminatory Level

February 23

Improving the Quality of Newborn Screening for Cystic Fibrosis

February 9

Assessing How Demographic Variables Affect Interpretation of MR-proANP in Heart Failure

January 26

Rethinking Prenatal Down Syndrome Screening

January 12

Assessing Diabetic Ketoacidosis in the Emergency Department
Page Access: